US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

CRVO

CervoMed (CRVO)

CervoMed Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CRVO

1

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/15	21 : 00	GlobeNewswire Inc.	CervoMed Reports First Quarter 2024 Financial Results and Provides Corporate Updates	NASDAQ:CRVO	CervoMed Inc
2024/04/01	21 : 00	GlobeNewswire Inc.	CervoMed Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates	NASDAQ:CRVO	CervoMed Inc
2024/03/28	21 : 30	GlobeNewswire Inc.	CervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare Investors	NASDAQ:CRVO	CervoMed Inc
2024/03/05	22 : 00	GlobeNewswire Inc.	CervoMed Announces Presentation of Biomarker Data from the AscenD-LB Phase 2a Trial and Preclinical Data Supporting Potential of Neflamapimod in Tau-Mediated Disease at AD/PD ™ 2024	NASDAQ:CRVO	CervoMed Inc
2024/02/21	22 : 00	GlobeNewswire Inc.	CervoMed to Participate in the BIO CEO and Investor Conference	NASDAQ:CRVO	CervoMed Inc
2024/02/12	22 : 00	GlobeNewswire Inc.	CervoMed Publishes Positive Results from AscenD-LB Phase 2a Trial in Peer-Reviewed Journal that Supports the Therapeutic Potential of Neflamapimod in Dementia with Lewy Bodies	NASDAQ:CRVO	CervoMed Inc
2024/02/07	22 : 30	GlobeNewswire Inc.	CervoMed Announces Appointment of Industry Leader Joshua Boger, Ph.D., as Chair of the Board	NASDAQ:CRVO	CervoMed Inc
2024/02/05	22 : 00	GlobeNewswire Inc.	CervoMed to Participate in the Emerging Growth Conference 67	NASDAQ:CRVO	CervoMed Inc
2024/01/05	22 : 00	GlobeNewswire Inc.	CervoMed to Participate in the Emerging Growth Conference 66	NASDAQ:CRVO	CervoMed Inc
2023/11/13	21 : 00	PR Newswire (US)	CervoMed Reports Third Quarter 2023 Financial Results and Business Highlights	NASDAQ:CRVO	CervoMed Inc
2023/10/26	03 : 50	PR Newswire (US)	CervoMed Announces Oral Presentation at CTAD 2023 Highlighting Learnings from Phase 2a Which Optimized the Design of the Phase 2b Clinical Study of Neflamapimod in Dementia with Lewy Bodies	NASDAQ:CRVO	CervoMed Inc
2023/10/24	20 : 00	PR Newswire (US)	CervoMed Announces Publications in Major Peer-Reviewed Journals That Inform on Potential of Neflamapimod as a Disease-Modifying Therapy for the Major Dementias	NASDAQ:CRVO	CervoMed Inc
2023/10/18	20 : 00	PR Newswire (US)	CervoMed Announces Oral Presentation at CTAD 2023 Highlighting Phase 2b Neflamapimod Program for the Treatment of Patients with Dementia with Lewy Bodies	NASDAQ:CRVO	CervoMed Inc
2023/10/05	20 : 00	PR Newswire (US)	CervoMed to Present at the 2023 Roth Healthcare Opportunities Conference	NASDAQ:CRVO	CervoMed Inc
2023/09/05	20 : 00	PR Newswire (US)	CervoMed to Present at H.C. Wainwright 25th Annual Global Investment Conference	NASDAQ:CRVO	CervoMed Inc

Showing the most relevant articles for your search:NASDAQ:CRVO

1

Societe Generale Effekten

J and T Global Express (PK)

Societe Generale Effekten

ISHARES EWSP INAV

BNP Paribas Issuance

ELETU360 Ex:35,6

CONSUMER TURNOVER 13/05/24

BlackRock Institutional ...

XUSD Stablecoin

Lyxor German MidCap MDAX...

BNP Paribas Issuance

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約